Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans.
Thorarensen, Atli
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. [electronic resource] - Journal of medicinal chemistry 03 2017 - 1971-1993 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1520-4804
10.1021/acs.jmedchem.6b01694 doi
Administration, Oral
Drug Design
Humans
Janus Kinase 3--antagonists & inhibitors
Protein Kinase Inhibitors--administration & dosage
Pyrimidines--administration & dosage
Pyrroles--administration & dosage
Signal Transduction--drug effects
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. [electronic resource] - Journal of medicinal chemistry 03 2017 - 1971-1993 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1520-4804
10.1021/acs.jmedchem.6b01694 doi
Administration, Oral
Drug Design
Humans
Janus Kinase 3--antagonists & inhibitors
Protein Kinase Inhibitors--administration & dosage
Pyrimidines--administration & dosage
Pyrroles--administration & dosage
Signal Transduction--drug effects